WebBACKGROUND Triple antiplatelet therapy might have beneficial effect to prevent thrombotic complications in patients undergoing coronary stenting. METHODS Patients undergoing successful coronary stenting were divided into dual antiplatelet therapy (aspirin plus clopidogrel or ticlopidine, group I, n ϭ 1,597) and triple antiplatelet therapy more ... Webn Sollte vorübergehend eine Dreifach-(„Triple“-)Therapie mit ASS, Clopidogrel und Phenprocou-mon erhalten. n Die INR sollte dann nur zwischen 2,0 und 2,5 liegen. ... bei beschichtetem Stent je nach Art der Beschichtung 1-3 Monate dreifache Gerinnungshem-mung. Dann Phenprocoumon und Clopidogrel für 6-12 Monate, danach nur noch …
Triple Antithrombotic Therapy in Patients With Atrial
WebOct 5, 2015 · In summary, patients treated with double therapy had a significantly lower risk of bleeding than those on triple therapy. Moreover, there were no significant differences between the two groups in the risk of myocardial infarction, stroke, target vessel revascularization or stent thrombosis. Click to read the study in The Lancet WebSep 15, 2014 · The need for triple therapy with aspirin, clopidogrel, and a vitamin K antagonist is a commonly encountered clinical scenario in patients undergoing percutaneous coronary intervention (PCI), with concomitant conditions such as atrial fibrillation (AF) or venous thromboembolism (VTE). bonhoff tube
Diagnostik und Therapie von Aortenerkrankungen - Neue Leitlinien …
WebSeitenthema: "Diagnostik und Therapie von Aortenerkrankungen - Neue Leitlinien der Europäischen Gesellschaft für Kardiologie 2014 - ERN ...". Erstellt von: Ulrich Hirsch. Sprache: deutsch. WebSep 15, 2024 · [0002] The disclosure relates to a triple-agent therapy for systemic treatment of cancer, particularly to the combination of tamoxifen, gefitinib, and vinorelbine (“TGV”) in the treatment of a broad range of cancers. ... Desperate this, the patient was admitted to receive the TGV therapy. A stent was placed in her esophagus. Tumor specimen ... WebMar 9, 2024 · Long-term antiplatelet therapy after coronary stenting significantly lowers the risk of stent thrombosis. Options for long-term antiplatelet therapy include dual antiplatelet therapy (DAPT; aspirin plus platelet P2Y 12 receptor blocker) or single antiplatelet therapy (aspirin or P2Y12 receptor blocker). There is also some evidence to support ... bonhay road